COVID-19 and rheumatology: first steps towards a different future?
Open Access
- 15 April 2020
- journal article
- editorial
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 79 (5), 551-552
- https://doi.org/10.1136/annrheumdis-2020-217494
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19New England Journal of Medicine, 2020
- Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapiesAnnals Of The Rheumatic Diseases, 2020
- To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemicAnnals Of The Rheumatic Diseases, 2020
- Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID‐19)Journal of Internal Medicine, 2020
- Could Chloroquine /Hydroxychloroquine Be Harmful in Coronavirus Disease 2019 (COVID-19) Treatment?Clinical Infectious Diseases, 2020
- Clinical and immunological features of severe and moderate coronavirus disease 2019JCI Insight, 2020
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trialInternational Journal of Antimicrobial Agents, 2020
- COVID-19: consider cytokine storm syndromes and immunosuppressionThe Lancet, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020